Keith Wesnes

Active 1983–2021

109
Papers
18,276
Citations
88
h-index
107
i10-index

Citations

Citations per year for Keith Wesnes1958: 1 citations1983: 5 citations1984: 9 citations1985: 3 citations1986: 27 citations1987: 17 citations1988: 30 citations1989: 24 citations1990: 20 citations1991: 26 citations1992: 46 citations1993: 27 citations1994: 31 citations1995: 27 citations1996: 27 citations1997: 21 citations1998: 34 citations1999: 41 citations2000: 88 citations2001: 82 citations2002: 156 citations2003: 174 citations2004: 155 citations2005: 170 citations2006: 157 citations2007: 178 citations2008: 184 citations2009: 176 citations2010: 177 citations2011: 189 citations2012: 176 citations2013: 154 citations2014: 150 citations2015: 140 citations2016: 133 citations2017: 121 citations2018: 122 citations2019: 399 citations2020: 409 citations2021: 371 citations2022: 279 citations2023: 168 citations2024: 227 citations2025: 111 citations2026: 4 citations1959–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,519 citing papers, 23.9% of this breakdownUnited Kingdom: 971 citing papers, 15.3% of this breakdownAustralia: 339 citing papers, 5.3% of this breakdownCanada: 295 citing papers, 4.7% of this breakdownItaly: 279 citing papers, 4.4% of this breakdownChina: 255 citing papers, 4% of this breakdownGermany: 243 citing papers, 3.8% of this breakdownFrance: 203 citing papers, 3.2% of this breakdownNetherlands: 175 citing papers, 2.8% of this breakdownSpain: 172 citing papers, 2.7% of this breakdownJapan: 147 citing papers, 2.3% of this breakdownSwitzerland: 117 citing papers, 1.8% of this breakdown
0%23.9%Other 25.8%

Fields

  • Medicine58.2%
  • Neuroscience16.7%
  • Biochemistry, Genetics and Molecular Biology10%
  • Psychology3.8%
  • Health Professions2.1%
  • Pharmacology, Toxicology and Pharmaceutics2%
  • Other7.2%

Topics

  • Dementia and Cognitive Impairment Research5.7%
  • Parkinson's Disease Mechanisms and Treatments4%
  • Alzheimer's disease research and treatments2.9%
  • Nicotinic Acetylcholine Receptors Study2.5%
  • Cholinesterase and Neurodegenerative Diseases2.4%
  • Functional Brain Connectivity Studies1.7%
  • Other80.8%

Coauthors

All papers

Open in search
  1. Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults

    Authors: , , , , , , , , , - American Journal of Geriatric Psychiatry 2019 cited by 216

  2. Characterizing mild cognitive impairment in incident Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , , - Neurology 2013 cited by 421

  3. Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials

    Authors: , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2015 cited by 334

  4. Nutrition for the ageing brain: Towards evidence for an optimal diet

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Ageing Research Reviews 2016 cited by 231

  5. AROMAS OF ROSEMARY AND LAVENDER ESSENTIAL OILS DIFFERENTIALLY AFFECT COGNITION AND MOOD IN HEALTHY ADULTS

    Authors: , , , - International Journal of Neuroscience 2003 cited by 462

  6. MODULATION OF COGNITIVE PERFORMANCE AND MOOD BY AROMAS OF PEPPERMINT AND YLANG-YLANG

    Authors: , , , - International Journal of Neuroscience 2007 cited by 211

  7. FLAME: A computerized neuropsychological composite for trials in early dementia

    Authors: , , , , , , , , , , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020 cited by 50

  8. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

    Authors: , , , , , , , , - The Lancet 2000 cited by 1,183

  9. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine

    Authors: , , , - Psychopharmacology 2005 cited by 356

  10. The effects of l-theanine, caffeine and their combination on cognition and mood

    Authors: , , , , - Biological Psychology 2007 cited by 270

  11. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale

    Authors: , , , , , , - The British Journal of Psychiatry 2000 cited by 369

  12. Poor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Ageing Research Reviews 2017 cited by 165

  13. Nicotine treatment of mild cognitive impairment

    Authors: , , , , , , , , , - Neurology 2012 cited by 217

  14. Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial

    Authors: , , , , , , , - Journal of Psychopharmacology 2013 cited by 151

  15. Visual perception in Parkinson disease dementia and dementia with Lewy bodies

    Authors: , , , , , - Neurology 2004 cited by 294

  16. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)

    Authors: , , , , - Pharmacology Biochemistry and Behavior 2002 cited by 248

  17. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers

    Authors: , , , , , - Physiology & Behavior 2004 cited by 162

  18. Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60–75 years?

    Authors: , , , , , - Behavioural Brain Research 2020 cited by 24

  19. The Neurocognitive Effects of Bacopa monnieri and Cognitive Training on Markers of Brain Microstructure in Healthy Older Adults

    Authors: , , , - Frontiers in Aging Neuroscience 2021 cited by 23

  20. Cognitive profiles in obstructive sleep apnea: a cluster analysis in sleep clinic and community samples

    Authors: , , , , , , , , - Journal of Clinical Sleep Medicine 2020 cited by 22

  21. Modulation of Mood and Cognitive Performance Following Acute Administration of Single Doses of Melissa Officinalis (Lemon Balm) with Human CNS Nicotinic and Muscarinic Receptor-Binding Properties

    Authors: , , , , , , - Neuropsychopharmacology 2003 cited by 197

  22. Effects of Armodafinil in the Treatment of Residual Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea Syndrome: A 12-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study in nCPAP-Adherent Adults

    Authors: , , , , , , - Clinical Therapeutics 2006 cited by 143

  23. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome

    Authors: , , , , , - Respiratory Medicine 2006 cited by 130

  24. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies

    Authors: , , , - International Journal of Geriatric Psychiatry 2014 cited by 104